Medical technology company Zenicor has won a tender with the North Savo region and Kuopio University Hospital in Finland, according to a press release.
The agreement is worth just over SEK 1 million and covers the company’s ECG solution, Zenicor One, which will be used to investigate cardiac arrhythmias and prevent strokes.
The solution will be used for both adults and children, as well as to identify undiagnosed atrial fibrillation in stroke patients.
Zenicor is already a supplier to the hospital in Kuopio. The new agreement entails expanded use throughout the entire North Savo region.